Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00570843 · ClinicalTrials.gov registry record · Phase 4
Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses
A Phase 4 study of Comfort, Vision and Wear Time, sponsored by Bp Consulting.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00570843 is a Phase 4 study of Comfort, Vision and Wear Time that has completed, run by Bp Consulting. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00570843, a Phase 4 study of Comfort, Vision and Wear Time, has completed, sponsored by Bp Consulting.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the effect of a new PEG based artificial tear as compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.
Conditions Studied
Interventions
- DRUG New PEG based artificial tear
- DRUG Optive
Study Locations (1)
New York
- The New York Presbyterian Hospital-Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00570843
The ClinicalTrials.gov registry entry for NCT00570843 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bp Consulting, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Comfort, Vision and Wear Time appearing as the primary indexed condition, and to 2 interventions - of which New PEG based artificial tear is the first listed.
NCT00570843 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00570843 about?
NCT00570843 is a clinical study titled "Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses". The objective of this study is to evaluate the effect of a new PEG based artificial tear as compared to Optive on comfort, wear time, and vision in patients wearing contact lenses.
What is the current status of trial NCT00570843?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2008-03. Estimated completion is 2010-02.
What conditions does trial NCT00570843 study?
This clinical trial studies the following conditions: Comfort, Vision and Wear Time.
What interventions are being tested in trial NCT00570843?
The interventions under investigation include: New PEG based artificial tear (DRUG), Optive (DRUG).
Who is sponsoring clinical trial NCT00570843?
This trial is sponsored by Bp Consulting, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00570843 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.